![Cornelius S. Sobel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Cornelius S.
Sobel is Head-European Development & Regulatory Affairs at Dragonfly Sciences, Inc.
Dr. Sobel was previously employed as Chief Scientific Officer by Biopartners GmbH and Head-Production & Regulatory Affairs by Merck KGaA.
He received his undergraduate degree from The Johannes Gutenberg University of Mainz.
| Sociétés | Poste | Fin |
|---|---|---|
Dragonfly Sciences, Inc.
 Dragonfly Sciences, Inc. BiotechnologyHealth Technology Develops biosimilar products of monoclonal antibodies and soluble receptors | Conseiller Juridique Général | - |
| MERCK KGAA | Conseiller Juridique Général | - |
Biopartners GmbH
 Biopartners GmbH Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis and virology | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis and virology | Health Technology |
Dragonfly Sciences, Inc.
Dragonfly Sciences, Inc. BiotechnologyHealth Technology Develops biosimilar products of monoclonal antibodies and soluble receptors | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
